|
|
Article: SINCLAIR PHARMA PLC - Sinclair, Orapharma terminate US Decapinol agreement.
- Article from:
- PR Newswire UK Disclose
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sinclair Pharma plc
Sinclair Pharma and Orapharma mutually agree to terminate US distribution
agreement for DecapinolA' mouth rinse
12 November 2009, Godalming, UK: Sinclair Pharma plc (the "Company" or
"Sinclair": SPH:L), the international specialty pharma company, today announces
that it has mutually agreed with Orapharma Inc to terminate with immediate
effect their distribution agreement for Decapinol mouth rinse, known as Impede,
in the US. Decapinol is an innovative product for treating gingivitis and
plaque and preventing periodontitis. Orapharma, a Johnson & Johnson subsidiary,
held US rights to the niche ...
Related newspaper, magazine, and journal articles:
|
|
Article: SINCLAIR PHARMA PLC - Result of AGM.
PR Newswire UK Disclose;
December 8, 2008 ;
700+ words
...Sinclair Pharma plc AGM Statement 8th December 2008, Godalming, UK: Sinclair Pharma plc ( Sinclair ) announces that all ... the newly appointed Chairman of Sinclair Pharma plc, made the following comments during ...
|
|